Lai YR, Cappellini MD, Aydinok Y, Porter J, et al. An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results. Am J Hematol 2022;97:E281-E284.
PMID: 35560253